SCHEMBL7089501

SCHEMBL7089501

Brc1ccc(-c2[nH]nc3c2Cc2ccccc2-3)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.60
CHEK1 O14757 6/20 0.57
CDK1 P06493 1/20 0.56
CDK2 P24941 1/20 0.56
GSR P00390 1/20 0.47
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
MAPK10 P53779 1/20 0.43
PDGFRB P09619 2/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
METAP2 P50579 1/20 0.41
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089495 0.88 KDR (0.78) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL11861276 0.85 KDR (0.60) KDRCHEK1CDK1CDK2GSR
SCHEMBL11865843 0.85 KDR (0.60) KDRCHEK1CDK1CDK2GSR
SCHEMBL7701873 0.85 KDR (0.60) KDRCHEK1CDK1CDK2GSR
SCHEMBL27606078 0.85 KDR (0.60) KDRCHEK1CDK1CDK2GSR
SCHEMBL30583253 0.84 CDK1 (0.78) KDRCHEK1CDK1CDK2GSR
SCHEMBL4996872 0.84 CDK1 (0.78) KDRCHEK1CDK1CDK2GSR
SCHEMBL7094340 0.82 CHEK1 (0.56) KDRCHEK1CDK1CDK2GSR
SCHEMBL11861284 0.79 KDR (0.56) KDRCHEK1CDK1CDK2GSR
SCHEMBL27552268 0.79 KDR (0.52) KDRCHEK1CDK1CDK2GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed